中国女性乳腺癌筛查与早诊早治指南(2021,北京)

2021-03-15 中国肿瘤.2021.30(3):161-191.

乳腺癌是中国女性最常见的恶性肿瘤,发病率位居中国女性恶性肿瘤首位。国家癌症中心受国家卫生健康委员会疾病预防控制局委托,根据《世界卫生组织指南制定手册》制定本部女性乳腺癌筛查与早诊早治指南。制作系统评价

中文标题:

中国女性乳腺癌筛查与早诊早治指南(2021,北京)

发布机构:

发布日期:

2021-03-15

简要介绍:

乳腺癌是中国女性最常见的恶性肿瘤,发病率位居中国女性恶性肿瘤首位。国家癌症中心受国家卫生健康委员会疾病预防控制局委托,根据《世界卫生组织指南制定手册》制定本部女性乳腺癌筛查与早诊早治指南。制作系统评价流程参考Cochrane 协作网的方法,证据质量与推荐强度的分级采用推荐意见分级的评估、制定及评价方法,并根据国际实践指南报告规范条目进行报告。在系统评价结果的基础上,结合中国国情,综合考虑了证据的利弊、证据的质量、筛查经济成本、多学科临床调查对象的反馈和面对面的专家共识意见,针对乳腺癌筛查与早诊早治中适宜人群、技术流程等进行循证推荐,旨在规范女性乳腺癌筛查与早诊早治实践,提升中国女性乳腺癌防控效果。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国女性乳腺癌筛查与早诊早治指南_2021_北京_赫捷.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fcc9a1c0020e55c8, title=中国女性乳腺癌筛查与早诊早治指南(2021,北京), enTitle=, guiderFrom=中国肿瘤.2021.30(3):161-191., authorId=0, author=, summary=乳腺癌是中国女性最常见的恶性肿瘤,发病率位居中国女性恶性肿瘤首位。国家癌症中心受国家卫生健康委员会疾病预防控制局委托,根据《世界卫生组织指南制定手册》制定本部女性乳腺癌筛查与早诊早治指南。制作系统评价, cover=https://img.medsci.cn/2021328/1616864344116_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Mar 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>乳腺癌是中国女性最常见的恶性肿瘤,发病率位居中国女性恶性肿瘤首位。国家癌症中心受国家卫生健康委员会疾病预防控制局委托,根据《世界卫生组织指南制定手册》制定本部女性乳腺癌筛查与早诊早治指南。制作系统评价流程参考Cochrane 协作网的方法,证据质量与推荐强度的分级采用推荐意见分级的评估、制定及评价方法,并根据国际实践指南报告规范条目进行报告。在系统评价结果的基础上,结合中国国情,综合考虑了证据的利弊、证据的质量、筛查经济成本、多学科临床调查对象的反馈和面对面的专家共识意见,针对乳腺癌筛查与早诊早治中适宜人群、技术流程等进行循证推荐,旨在规范女性乳腺癌筛查与早诊早治实践,提升中国女性乳腺癌防控效果。</p> </div> </div> </div>, tagList=[TagDto(tagId=285, tagName=乳腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=285, guiderKeyword=乳腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=28853, appHits=471, showAppHits=0, pcHits=1489, showPcHits=28382, likes=3, shares=28, comments=32, approvalStatus=1, publishedTime=Sun Mar 28 00:59:20 CST 2021, publishedTimeString=2021-03-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 28 00:59:14 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 06:04:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国女性乳腺癌筛查与早诊早治指南_2021_北京_赫捷.pdf)])
中国女性乳腺癌筛查与早诊早治指南_2021_北京_赫捷.pdf
下载请点击:
评论区 (26)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1060068, encodeId=baac10600685d, content=对基层的医生帮助很多,感谢平台。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287a5185791, createdName=147079e4m68暂无昵称, createdTime=Wed Oct 13 10:42:50 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057060, encodeId=4d67105e06061, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa632433739, createdName=123c0344m97暂无昵称, createdTime=Sun Oct 03 08:41:34 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008898, encodeId=fe0c100889818, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18425528852, createdName=ms7000001778031297, createdTime=Wed Aug 18 06:23:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005080, encodeId=e04e10050802b, content=很棒,收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLSbjvTiba6RXwaDqQYrcVpkyav3QNhmlULBgzqsa7gYXic71mzb0B5KE0xNmAXs6pBg9ok8hCtfWng/132, createdBy=8ca01929846, createdName=msqsky, createdTime=Wed Aug 04 11:00:50 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001863, encodeId=33fc1001863f2, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d995423681, createdName=ms1000000191815941, createdTime=Thu Jul 22 23:25:04 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-10-13 147079e4m68暂无昵称

    对基层的医生帮助很多,感谢平台。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1060068, encodeId=baac10600685d, content=对基层的医生帮助很多,感谢平台。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287a5185791, createdName=147079e4m68暂无昵称, createdTime=Wed Oct 13 10:42:50 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057060, encodeId=4d67105e06061, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa632433739, createdName=123c0344m97暂无昵称, createdTime=Sun Oct 03 08:41:34 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008898, encodeId=fe0c100889818, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18425528852, createdName=ms7000001778031297, createdTime=Wed Aug 18 06:23:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005080, encodeId=e04e10050802b, content=很棒,收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLSbjvTiba6RXwaDqQYrcVpkyav3QNhmlULBgzqsa7gYXic71mzb0B5KE0xNmAXs6pBg9ok8hCtfWng/132, createdBy=8ca01929846, createdName=msqsky, createdTime=Wed Aug 04 11:00:50 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001863, encodeId=33fc1001863f2, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d995423681, createdName=ms1000000191815941, createdTime=Thu Jul 22 23:25:04 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-10-03 123c0344m97暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1060068, encodeId=baac10600685d, content=对基层的医生帮助很多,感谢平台。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287a5185791, createdName=147079e4m68暂无昵称, createdTime=Wed Oct 13 10:42:50 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057060, encodeId=4d67105e06061, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa632433739, createdName=123c0344m97暂无昵称, createdTime=Sun Oct 03 08:41:34 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008898, encodeId=fe0c100889818, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18425528852, createdName=ms7000001778031297, createdTime=Wed Aug 18 06:23:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005080, encodeId=e04e10050802b, content=很棒,收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLSbjvTiba6RXwaDqQYrcVpkyav3QNhmlULBgzqsa7gYXic71mzb0B5KE0xNmAXs6pBg9ok8hCtfWng/132, createdBy=8ca01929846, createdName=msqsky, createdTime=Wed Aug 04 11:00:50 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001863, encodeId=33fc1001863f2, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d995423681, createdName=ms1000000191815941, createdTime=Thu Jul 22 23:25:04 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-08-18 ms7000001778031297

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1060068, encodeId=baac10600685d, content=对基层的医生帮助很多,感谢平台。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287a5185791, createdName=147079e4m68暂无昵称, createdTime=Wed Oct 13 10:42:50 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057060, encodeId=4d67105e06061, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa632433739, createdName=123c0344m97暂无昵称, createdTime=Sun Oct 03 08:41:34 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008898, encodeId=fe0c100889818, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18425528852, createdName=ms7000001778031297, createdTime=Wed Aug 18 06:23:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005080, encodeId=e04e10050802b, content=很棒,收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLSbjvTiba6RXwaDqQYrcVpkyav3QNhmlULBgzqsa7gYXic71mzb0B5KE0xNmAXs6pBg9ok8hCtfWng/132, createdBy=8ca01929846, createdName=msqsky, createdTime=Wed Aug 04 11:00:50 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001863, encodeId=33fc1001863f2, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d995423681, createdName=ms1000000191815941, createdTime=Thu Jul 22 23:25:04 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-08-04 msqsky

    很棒,收藏了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1060068, encodeId=baac10600685d, content=对基层的医生帮助很多,感谢平台。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287a5185791, createdName=147079e4m68暂无昵称, createdTime=Wed Oct 13 10:42:50 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057060, encodeId=4d67105e06061, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa632433739, createdName=123c0344m97暂无昵称, createdTime=Sun Oct 03 08:41:34 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008898, encodeId=fe0c100889818, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18425528852, createdName=ms7000001778031297, createdTime=Wed Aug 18 06:23:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005080, encodeId=e04e10050802b, content=很棒,收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLSbjvTiba6RXwaDqQYrcVpkyav3QNhmlULBgzqsa7gYXic71mzb0B5KE0xNmAXs6pBg9ok8hCtfWng/132, createdBy=8ca01929846, createdName=msqsky, createdTime=Wed Aug 04 11:00:50 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001863, encodeId=33fc1001863f2, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d995423681, createdName=ms1000000191815941, createdTime=Thu Jul 22 23:25:04 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-07-22 ms1000000191815941

    厉害

    0

拓展阅读

乳腺癌HER2检测指南(2009版)

中国肿瘤科相关专家小组(统称) · 2009-12-01

2010 乳腺癌骨转移和骨相关疾病临床诊疗专家共识(2010版)

乳腺癌骨转移和骨相关疾病临床诊疗专家组 · 2010-01-01

2010 SBI/ACR推荐建议:乳腺癌影像学筛查

乳腺影像学会(SBI,Society of Breast Imaging) · 2010-01-20

2010 人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2010-02-01

2010 ASCO-CAP指南:乳腺癌患者雌激素和雄激素受体的免疫组化检测

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-04-19

2010 ASCO指南:激素受体阳性乳腺癌妇女的辅助内分泌治疗

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-07-12